Period Ending | Mar 30, 2012 | Mar 29, 2012 | Mar 31, 2011 |
---|
Total Revenue
|
6,730,000
|
6,730,000
|
6,190,000
| Cost of Revenue | 1,082,000 | 1,082,000 | 1,045,000 | |
Gross Profit
|
5,648,000
|
5,648,000
|
5,145,000
| |
|
Operating Expenses |
|
Research Development | 969,000 | 969,000 | 862,000 |
|
Selling General and Administrative | 3,251,000 | 3,251,000 | 3,012,000 |
|
Non Recurring | 60,000 | 60,000 | 121,000 |
|
Others | 289,000 | 289,000 | 270,000 |
|
|
|
Total Operating Expenses | 4,569,000 | 4,569,000 | 4,265,000 | | |
Operating Income or Loss
|
1,079,000
|
1,079,000
|
880,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 533,000 | 533,000 | (8,000) |
|
Earnings Before Interest And Taxes | 1,585,000 | 1,585,000 | 841,000 |
|
Interest Expense | 115,000 | 115,000 | 143,000 |
|
Income Before Tax | 1,470,000 | 1,470,000 | 698,000 |
|
Income Tax Expense | 298,000 | 298,000 | 105,000 |
|
Minority Interest |
-
|
-
| 4,000 |
|
|
|
Net Income From Continuing Ops | 1,145,000 | 1,145,000 | 550,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
1,172,000
|
1,172,000
|
597,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,172,000
|
1,172,000
|
597,000
|
|